Featured Story | By Annalee Armstrong After years in development, the floodgates for RSV vaccines may open up soon, with more and more Big Pharmas piling on data. Now, Johnson & Johnson’s Janssen is adding to the fray, announcing efficacy as high as 80% in preventing severe infections in a mid-stage clinical trial. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor When Amgen splashed $400 million upfront on Kyowa Kirin’s anti-OX40 antibody, the world was yet to see midphase data on the prospect. Amgen and Kyowa lifted the lid on the data over the weekend in a presentation of phase 2 results in eczema patients. read more By Nick Paul Taylor The race to use bispecifics to treat blood cancers is heating up, with Johnson & Johnson paying $100 million upfront to challenge Regeneron and Roche in a field that looks set to be highly competitive. read more Sponsored By: Taconic Biosciences Pressure to get results in drug discovery and development is unprecedented and the need for genetically engineered custom mouse models is greater than ever. Innovative thinking is getting these critical models into researchers hands faster. read more By Nick Paul Taylor Enanta Pharmaceuticals is tearing up its NASH strategy. After getting a look at interim phase 2b data, the biotech has decided to stop the monotherapy trial and seek to outlicense its candidates for use in combinations. read more Sponsored by: Almac Group PanCan utilised Almac's IRT expertise to accelerate their adaptive platform outcomes and improve patient care. Find out how here. read more By Ben Adams After a tough pre-pandemic rout that saw it slash staff, steer around a cash crunch and face a bitter setback in the clinic, Selecta Biosciences is bouncing back with a major new biobucks pact with Japan’s Takeda. read more By Kyle LaHucik Five months after former Chief Medical Officer John Davis, M.D., said he'd hit the exit, Magenta Therapeutics has found a replacement in Constellation CMO Jeffrey Humphrey. The new hire comes after Magenta was able to clear a phase 1/2 clinical trial in blood cancer last month following a setback in July. read more By Arlene Weintraub Michigan State University researchers discovered that glial cells actively modify electrical signals in the gut to maintain normal functions like motility. They believe the findings could inspire new treatments for common conditions like inflammatory bowel disease and other motility disorders. read more By Robert King Providers are united in opposition to the Biden administration's latest surprise billing rule, claiming it tilts a dispute resolution process in payers' favor. read more By Conor Hale The Talisman device builds off the company’s previous Amplatzer occluder for treating a patent foramen ovale, a gap that forms during fetal development and allows blood to pass through the heart’s right and left atria. read more By Beth Snyder Bulik After a year when it seems like creativity should have hit a pause, the Fierce Pharma Marketing Award winners are proof of just the opposite. read more Resources Sponsored By: Trial Interactive Check out the eTMF Implementation Quick Guide to see a checklist TMF experts developed to help you reduce risks, maintain compliance, and establish effective processes in your eTMF. Sponsored By: Bioclinica This whitepaper addresses where AI can make the biggest impact in clinical trials. Sponsored by: Thermo Fisher Scientific Looking to accelerate your biotech company, but not sure where to start? Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. Sponsored by: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: LabVantage Solutions Shift from data collection to data science. Add advanced analytics to your lab informatics platform to yield valuable, action-ready insights from LIMS and other data. Sponsored by: Thermo Fisher Scientific Integrate supply chain simulation into your early clinical trial planning to minimize risk in an uncertain supply chain environment, improve supply chain outcomes, and help streamline time-to-market for innovative therapies. Sponsored by: WCG Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. | 
